Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring These thresholds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback